Q1 FY2026 · ended Mar 31, 2026 · Revenue $5.49M, -32.8% YoY · Filed May 14, 2026
Synergy CHC Corp. (SNYRQ) files with the SEC under industry code 2833, Medicinal Chemicals & Botanical Products. In Q1 of fiscal 2026, the quarter ended Mar 31, 2026, it reported revenue of $5.5 million and a net loss of $2.6 million. As of Mar 31, 2026 it held $292,115 in cash and investments and $25.0 million in total debt.
Revenue
$5.49M
-32.8% vs year-ago quarter
Net income
$-2.57M
-393.2% vs year-ago quarter
Operating cash flow
$-2.04M
-148.5% vs year-ago quarter
Free cash flow
—
EPS
$-0.23
-330.0% vs year-ago quarter
Dividend per share
None
Shares outstanding
14.90M
+65.3% vs year-ago quarter
Net cash
$-24.73M
Q1 FY2026
Operating margin
-39.6%
TTM
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- SNYRQ (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Westbrook, ME
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1562733
- Former names
- Synergy Strips Corp. (until Aug 6, 2015); Oro Capital Corporation, Inc. (until Apr 24, 2014)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
Q1 FY2025 Mar 31, 2025 |
|---|---|---|---|---|---|
| Revenue | $5.5M | $6.1M | $8.0M | $8.1M | $8.2M |
| Operating income | -$567,120 | -$13.3M | $1.3M | $1.6M | $1.9M |
| Net income | -$2.6M | -$14.8M | $125,327 | $1.5M | $876,264 |
| Diluted EPS | -$0.23 | -$1.32 | $0.01 | $0.17 | $0.10 |
| Operating cash flow | -$2.0M | $624,127 | -$2.3M | -$76,950 | -$822,781 |
| Total assets | $6.5M | $10.2M | $20.7M | $19.7M | $15.7M |
| Total liabilities | $31.9M | $33.3M | $28.9M | $32.1M | $31.3M |
| Stockholders' equity | -$25.4M | -$23.1M | -$8.3M | -$12.4M | -$15.6M |
| Cash and investments | $292,115 | $2.6M | $1.0M | $1.5M | $177,882 |
| Total debt | $25.0M | $25.2M | $25.1M | $26.9M | $15.7M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Listing notice
|
Sep 16, 2026 | Sep 11, 2026 |
| 8-K |
Current report
Bankruptcy, Officer or director change
|
Sep 8, 2026 | Sep 4, 2026 |
| 8-K | Current report | Aug 26, 2026 | Aug 25, 2026 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Aug 21, 2026 | Aug 20, 2026 |
| 8-K | Current report | Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Other events
|
Jul 29, 2026 | Jul 15, 2026 |
All 252 Synergy CHC Corp. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.